Egr-1: New conductor for the tissue repair orchestra directs harmony (regeneration) or cacophony (fibrosis)

Swati Bhattacharyya, Feng Fang, Warren Tourtellotte, John Varga*

*Corresponding author for this work

Research output: Contribution to journalReview article

74 Citations (Scopus)

Abstract

Fibroblasts and myofibroblasts are the key effector cells executing physiological tissue repair leading to regeneration on the one hand, and pathological fibrogenesis leading to chronic fibrosing conditions on the other. Recent studies identify the multifunctional transcription factor early growth response-1(Egr-1) as an important mediator of fibroblast activation triggered by diverse stimuli. Egr-1 has potent stimulatory effects on fibrotic gene expression, and aberrant Egr-1 expression or function is associated with animal models of fibrosis and human fibrotic disorders, including emphysema, pulmonary fibrosis, pulmonary hypertension and systemic sclerosis. Pharmacological suppression or genetic targeting of Egr-1 blocks fibrotic responses in vitro and ameliorates experimental fibrosis in the skin and lung. In contrast, Egr-1 appears to act as a negative regulator of hepatic fibrosis in mouse models, suggesting a context-dependent role in fibrosis. The Egr-1-binding protein Nab2 is an endogenous inhibitor of Egr-1-mediated signalling and abrogates the stimulation of fibrotic responses induced by transforming growth factor-β (TGFβ). Moreover, mice deficient in Nab2 show excessive collagen accumulation in the skin. These observations highlight a previously unsuspected fundamental physiological function for the Egr-1-Nab2 signalling axis in regulating fibrogenesis, and suggest that Egr-1 may be a potential novel therapeutic target in human diseases complicated by fibrosis. This review summarizes recent advances in understanding the regulation and complex functional role of Egr-1 and its related proteins and inhibitors in pathological fibrosis.

Original languageEnglish (US)
Pages (from-to)286-297
Number of pages12
JournalJournal of Pathology
Volume229
Issue number2
DOIs
StatePublished - Jan 1 2013

Fingerprint

Regeneration
Fibrosis
Growth
Early Growth Response Protein 1
Fibroblasts
Genetic Suppression
Growth Inhibitors
Skin
Myofibroblasts
Pulmonary Fibrosis
Systemic Scleroderma
Emphysema
Transforming Growth Factors
Pulmonary Hypertension
Carrier Proteins
Collagen
Animal Models
Pharmacology
Gene Expression
Lung

Keywords

  • Egr-1
  • Nab2
  • TGF β
  • c-Abl
  • fibroblast
  • fibrosis
  • myofibroblast
  • p300
  • scleroderma

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

@article{fa2348834c37456bba24936268dd76c7,
title = "Egr-1: New conductor for the tissue repair orchestra directs harmony (regeneration) or cacophony (fibrosis)",
abstract = "Fibroblasts and myofibroblasts are the key effector cells executing physiological tissue repair leading to regeneration on the one hand, and pathological fibrogenesis leading to chronic fibrosing conditions on the other. Recent studies identify the multifunctional transcription factor early growth response-1(Egr-1) as an important mediator of fibroblast activation triggered by diverse stimuli. Egr-1 has potent stimulatory effects on fibrotic gene expression, and aberrant Egr-1 expression or function is associated with animal models of fibrosis and human fibrotic disorders, including emphysema, pulmonary fibrosis, pulmonary hypertension and systemic sclerosis. Pharmacological suppression or genetic targeting of Egr-1 blocks fibrotic responses in vitro and ameliorates experimental fibrosis in the skin and lung. In contrast, Egr-1 appears to act as a negative regulator of hepatic fibrosis in mouse models, suggesting a context-dependent role in fibrosis. The Egr-1-binding protein Nab2 is an endogenous inhibitor of Egr-1-mediated signalling and abrogates the stimulation of fibrotic responses induced by transforming growth factor-β (TGFβ). Moreover, mice deficient in Nab2 show excessive collagen accumulation in the skin. These observations highlight a previously unsuspected fundamental physiological function for the Egr-1-Nab2 signalling axis in regulating fibrogenesis, and suggest that Egr-1 may be a potential novel therapeutic target in human diseases complicated by fibrosis. This review summarizes recent advances in understanding the regulation and complex functional role of Egr-1 and its related proteins and inhibitors in pathological fibrosis.",
keywords = "Egr-1, Nab2, TGF β, c-Abl, fibroblast, fibrosis, myofibroblast, p300, scleroderma",
author = "Swati Bhattacharyya and Feng Fang and Warren Tourtellotte and John Varga",
year = "2013",
month = "1",
day = "1",
doi = "10.1002/path.4131",
language = "English (US)",
volume = "229",
pages = "286--297",
journal = "Journal of Pathology",
issn = "0022-3417",
publisher = "John Wiley and Sons Ltd",
number = "2",

}

Egr-1 : New conductor for the tissue repair orchestra directs harmony (regeneration) or cacophony (fibrosis). / Bhattacharyya, Swati; Fang, Feng; Tourtellotte, Warren; Varga, John.

In: Journal of Pathology, Vol. 229, No. 2, 01.01.2013, p. 286-297.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Egr-1

T2 - New conductor for the tissue repair orchestra directs harmony (regeneration) or cacophony (fibrosis)

AU - Bhattacharyya, Swati

AU - Fang, Feng

AU - Tourtellotte, Warren

AU - Varga, John

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Fibroblasts and myofibroblasts are the key effector cells executing physiological tissue repair leading to regeneration on the one hand, and pathological fibrogenesis leading to chronic fibrosing conditions on the other. Recent studies identify the multifunctional transcription factor early growth response-1(Egr-1) as an important mediator of fibroblast activation triggered by diverse stimuli. Egr-1 has potent stimulatory effects on fibrotic gene expression, and aberrant Egr-1 expression or function is associated with animal models of fibrosis and human fibrotic disorders, including emphysema, pulmonary fibrosis, pulmonary hypertension and systemic sclerosis. Pharmacological suppression or genetic targeting of Egr-1 blocks fibrotic responses in vitro and ameliorates experimental fibrosis in the skin and lung. In contrast, Egr-1 appears to act as a negative regulator of hepatic fibrosis in mouse models, suggesting a context-dependent role in fibrosis. The Egr-1-binding protein Nab2 is an endogenous inhibitor of Egr-1-mediated signalling and abrogates the stimulation of fibrotic responses induced by transforming growth factor-β (TGFβ). Moreover, mice deficient in Nab2 show excessive collagen accumulation in the skin. These observations highlight a previously unsuspected fundamental physiological function for the Egr-1-Nab2 signalling axis in regulating fibrogenesis, and suggest that Egr-1 may be a potential novel therapeutic target in human diseases complicated by fibrosis. This review summarizes recent advances in understanding the regulation and complex functional role of Egr-1 and its related proteins and inhibitors in pathological fibrosis.

AB - Fibroblasts and myofibroblasts are the key effector cells executing physiological tissue repair leading to regeneration on the one hand, and pathological fibrogenesis leading to chronic fibrosing conditions on the other. Recent studies identify the multifunctional transcription factor early growth response-1(Egr-1) as an important mediator of fibroblast activation triggered by diverse stimuli. Egr-1 has potent stimulatory effects on fibrotic gene expression, and aberrant Egr-1 expression or function is associated with animal models of fibrosis and human fibrotic disorders, including emphysema, pulmonary fibrosis, pulmonary hypertension and systemic sclerosis. Pharmacological suppression or genetic targeting of Egr-1 blocks fibrotic responses in vitro and ameliorates experimental fibrosis in the skin and lung. In contrast, Egr-1 appears to act as a negative regulator of hepatic fibrosis in mouse models, suggesting a context-dependent role in fibrosis. The Egr-1-binding protein Nab2 is an endogenous inhibitor of Egr-1-mediated signalling and abrogates the stimulation of fibrotic responses induced by transforming growth factor-β (TGFβ). Moreover, mice deficient in Nab2 show excessive collagen accumulation in the skin. These observations highlight a previously unsuspected fundamental physiological function for the Egr-1-Nab2 signalling axis in regulating fibrogenesis, and suggest that Egr-1 may be a potential novel therapeutic target in human diseases complicated by fibrosis. This review summarizes recent advances in understanding the regulation and complex functional role of Egr-1 and its related proteins and inhibitors in pathological fibrosis.

KW - Egr-1

KW - Nab2

KW - TGF β

KW - c-Abl

KW - fibroblast

KW - fibrosis

KW - myofibroblast

KW - p300

KW - scleroderma

UR - http://www.scopus.com/inward/record.url?scp=84871066557&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871066557&partnerID=8YFLogxK

U2 - 10.1002/path.4131

DO - 10.1002/path.4131

M3 - Review article

C2 - 23132749

AN - SCOPUS:84871066557

VL - 229

SP - 286

EP - 297

JO - Journal of Pathology

JF - Journal of Pathology

SN - 0022-3417

IS - 2

ER -